A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

Yale University, New Haven, Connecticut, United States

START Midwest, Grand Rapids, Michigan, United States

Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland, Ohio, United States

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Hämatologisch-Onkologische Praxis Eppendorf - HOPE, Hamburg, Germany

Asklepios Tumorzentrum Hamburg, Hamburg, Germany

National Cancer Center Hospital, Chūōku, Japan

National Cancer Center Hospital East, Kashiwa, Japan

Hospital HM Nou Delfos, Barcelona, Spain

Vall D'Hebrón Hospital, Barcelona, Spain

Centro Integral Oncologico Clara Campal, Madrid, Spain

Guy's & St Thomas' NHS Foundation Trust, Guy's Hospital, London, United Kingdom

Christie NHS Foundation, Manchester, United Kingdom

The Royal Marsden NHS, Sutton, United Kingdom